Matthew H. Daniels
17Patents
5h-index
91Co-inventors
65Inventor score
Filing activity: Jan 29, 2010 → Mar 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9663522B2 | 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 15 | Active |
| US9663502B2 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Chemistry; Metallurgy | 12 | Active |
| US9783511B2 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 9 | Active |
| US9809561B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 8 | Active |
| US10221146B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 6 | Active |
| US9023865B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10654850B2 | Pyridazinones and methods of use thereof | Human Necessities | 1 | Active |
| US12233065B2 | Inhibitors of RNA helicase DHX9 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10745364B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US11623930B2 | Imidazodiazepinediones and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12162867B2 | Inhibitors of RNA helicase DHX9 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9227971B2 | Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11046690B2 | Pyridazinones and methods of use thereof | Human Necessities | 0 | Active |
| US9226922B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8609897B2 | Trifluoromethylsulfonamide gamma secretase inhibitor | Chemistry; Metallurgy | 0 | Active |
| US8999957B2 | Heterocyclic compounds as ERK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9233979B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.